SlideShare a Scribd company logo
1 of 2
Download to read offline
New Requirements for Benefit-Risk Assessments
Evolving global pharmacoviglance regulations have recently put the spot-light on finding better and quicker ways to
measure and assess medicinal product benefit-risk profiles through new requirements and guidelines.
Quintiles can help you better understand and comply with these changing regulations through our safety aggregate
reporting and benefit-risk assessment capabilities. Through our experienced staff, best-in-class processes, and proprietary
technology, we are able to deliver medical, scientific and regulatory reports that are timely, insightful, and stand up to
regulatory scrutiny.
Outstanding Pharmacovigilance Delivery
 Zero critical findings from customer audits1
 99% compliance for on-time reporting to health authorities1
 200+ medical and clinical professionals including medical
doctors, pharmacists, and life sciences graduates2
Bringing Together the Right Experts,
Around the Globe
 Cross-functional – Our team is comprised of physicians,
pharmacists, pharmacoepidemiologists, and regulatory
affairs professionals (including ex-FDA and European
regulatory agency staff) with a wealth of medical,
pharmaceutical, scientific and clinical expertise.
 Highly Trained - All staff are trained and experienced in
drug safety with particular focus on safety and efficacy
analysis and regulatory requirements, to help deliver the
highest quality and performance through our globally
compliant suite of SOPs and templates underpinned by a
range quality checklists.
 Global – Our staff is housed across 8 global hubs located
across North America, Europe and Asia. This globalization
of services allows for extensive regionalized expertise,
local-language translation, flexibility, improved cost
effectiveness and provides the ability to meet our client’s
local requirements, while never losing sight of safety and
risk management compliance on a global scale.
1
Source: Quintiles internal data. Metrics valid from November 2012 through
November 2013.
2
Source: Quintiles internal HRPSC data valid as of July 2013.
Safety Aggregate Reporting and Analytics
Team Core Training Modules
Aggregate Reporting Training
 Knowledge of Systems and Processes
 Training Transcript Review
 Subject Matter Expert Mentoring
Specialized Argus 7.0 Reports Training
 Individualized One-on-One Reports Training
 Subject Matter Expert Mentoring
Project Specific Training
• Product Safety Information (IB, CCDS, CCSI, USPI, SmPC)
Electronic Learning Management
• Safety Aggregate Reporting & Analytics Specific Electronic
Standard Operating Procedure (eSOP) Documents and
Assignments
• Electronic Training (eTraining) Management System
• Required Readings (Regulations/Guidances)
• Report Specific Courses With Knowledge Tests
• Process Maps
• Safety Aggregate Reporting Manual of Style
All team members receive extensive training and mentorship as part
of onboarding and continuing education.
Safety Aggregate Reporting & Analytics
PHARMACOVIGILANCE INSIGHTS
AT-A-GLANCE
Contact Us:
US Toll Free: 1 866 267 4479
Direct: +1 973 850 7571
On the web: www.quintiles.com/safety
Email: clinical@quintiles.com
Copyright © 2013 Quintiles. 02.02.20-122013
Proprietary Technology Driving Productivity, Compliance and Quality
Our Safety Aggregate Reporting and Analytics database tracks productivity, quality and compliance all in one place.
Productivity and Compliance are tracked by automation of key report milestones and tracked against actual delivery
throughout the report lifecycle. The Quality component is measured by a range of detailed report-specific checklists that
have been developed using Six-Sigma concepts.
Our database generates reports and scorecards both during in-line and end-of line review to help enable both Quintiles and
our customers to deliver top quality, on-time aggregate reports to regulators. The result? Increased transparency between
Quintiles and our customers throughout the entire report production process, allowing us to continually improve and excel
in our delivery.
Safety Aggregate Reporting and Analytics Services
Service Description Benefit
Signal Detection and
Analytics
 Analysis of Similar Events
 Suspected Unexpected Serious Adverse Reactions (SUSAR) and
Events of Special Inerest (EOSI) listings
 Routine signal detection and management (listings and count tables)
 J-review or Spotfire analysis of blinded clinical trial data
 Post-marketing Signal Detection: Oracle Empirica, FDA-AERS,
WHOVigibase, Electronic Health Record (EHR) data
 Post-marketing Signal Evaluation and Confirmation
 Pharmacoepidemiological studies
 Proprietary signal management tool enables tracking of validation,
prioritization, assessment, actioning, and reporting of signals
 Gain deeper insights
into your proudct’s
safety profile
 Understand off-label
use
Aggregate Reporting  Developmental Safety Update Report (DSUR)
 Periodic Benefit-Risk Evaluation Reports (PBRER)
 Periodic Safety Update Reports (PSUR)
 Periodic Adverse Drug Experience Report (PADER)
 IND Annual Safety Reports
 Pharmacovigilance Risk Assessment Committee (PRAC) responses
/ Regulatory Authority responses
 Meet new aggregate
reporting requirements
across multiple
countries and projects
with one, dedicated
team
Benefit-Risk
Management
 Risk Management Program Development & Implementation
 US: Risk Evaluation & Mitigation Strategy (REMS)
 EU Risk Management Plan (RMP)
 Safety Crisis Management
 Data Analysis & Risk Communications
 EU QPPV (Qualified Person for Pharmacovigilance for the EU)
 Label Creation and Maintenance
 Literature Search and ad hoc Benefit-Risk Assessments
 Understand and
communicate the
evolving benefit-risk
profile of your productrs
sooner

More Related Content

What's hot

Aggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLSAggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLSKatalyst HLS
 
Planning for the New Individual Case Safety Report (ICSR) International Stand...
Planning for the New Individual Case Safety Report (ICSR) International Stand...Planning for the New Individual Case Safety Report (ICSR) International Stand...
Planning for the New Individual Case Safety Report (ICSR) International Stand...Perficient
 
Signal detection and management
Signal detection and managementSignal detection and management
Signal detection and managementsekharbabu41
 
Development safety update report (dsur) pharmacovigilance and safety
Development safety update report (dsur)   pharmacovigilance and safetyDevelopment safety update report (dsur)   pharmacovigilance and safety
Development safety update report (dsur) pharmacovigilance and safetyAzierta
 
Argus Aggregrate Reporting_Katalyst HLS
Argus Aggregrate Reporting_Katalyst HLSArgus Aggregrate Reporting_Katalyst HLS
Argus Aggregrate Reporting_Katalyst HLSKatalyst HLS
 
Periodic Safety Update Report (PSUR)
Periodic Safety Update Report (PSUR)Periodic Safety Update Report (PSUR)
Periodic Safety Update Report (PSUR)Dr. Rohith K Nair
 
Evaluating and Investigating Drug Safety Signals with Public Databases
Evaluating and Investigating Drug Safety Signals with Public DatabasesEvaluating and Investigating Drug Safety Signals with Public Databases
Evaluating and Investigating Drug Safety Signals with Public DatabasesPerficient
 
Pharmacovigilance signal and signal detection
Pharmacovigilance signal and signal detectionPharmacovigilance signal and signal detection
Pharmacovigilance signal and signal detectionKiranRajput38
 
Presentation: Periodic safety update reports
Presentation: Periodic safety update reportsPresentation: Periodic safety update reports
Presentation: Periodic safety update reportsTGA Australia
 
Importance of aggregate reporting in pharmacovigilance
Importance of aggregate reporting in pharmacovigilanceImportance of aggregate reporting in pharmacovigilance
Importance of aggregate reporting in pharmacovigilanceSollers College
 
Periodic Safety Update Reports: Some commonly asked questions
Periodic Safety Update Reports: Some commonly asked questionsPeriodic Safety Update Reports: Some commonly asked questions
Periodic Safety Update Reports: Some commonly asked questionsTGA Australia
 
Literature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv   what are we doing at galderma elsevier webinarLiterature monitoring for pv   what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinarAnn-Marie Roche
 
TGA Presentation: Pharmacovigilance inspections
TGA Presentation: Pharmacovigilance inspectionsTGA Presentation: Pharmacovigilance inspections
TGA Presentation: Pharmacovigilance inspectionsTGA Australia
 
E2B(R2) vs E2B(R3) ICSR ELEMENTS
E2B(R2) vs E2B(R3) ICSR ELEMENTSE2B(R2) vs E2B(R3) ICSR ELEMENTS
E2B(R2) vs E2B(R3) ICSR ELEMENTSAnurag Raghuvanshi
 
Adverse Drug Reactions - Katalyst HLS
Adverse Drug Reactions - Katalyst HLSAdverse Drug Reactions - Katalyst HLS
Adverse Drug Reactions - Katalyst HLSKatalyst HLS
 
Practical Signal Management
Practical Signal ManagementPractical Signal Management
Practical Signal ManagementPerficient
 

What's hot (20)

Aggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLSAggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLS
 
Planning for the New Individual Case Safety Report (ICSR) International Stand...
Planning for the New Individual Case Safety Report (ICSR) International Stand...Planning for the New Individual Case Safety Report (ICSR) International Stand...
Planning for the New Individual Case Safety Report (ICSR) International Stand...
 
Med dra Basics
Med dra  BasicsMed dra  Basics
Med dra Basics
 
Signal detection and management
Signal detection and managementSignal detection and management
Signal detection and management
 
Development safety update report (dsur) pharmacovigilance and safety
Development safety update report (dsur)   pharmacovigilance and safetyDevelopment safety update report (dsur)   pharmacovigilance and safety
Development safety update report (dsur) pharmacovigilance and safety
 
Argus Aggregrate Reporting_Katalyst HLS
Argus Aggregrate Reporting_Katalyst HLSArgus Aggregrate Reporting_Katalyst HLS
Argus Aggregrate Reporting_Katalyst HLS
 
Introduction to post marketing drug safety surveillance fda 2-11-14
Introduction to post marketing drug safety surveillance fda 2-11-14Introduction to post marketing drug safety surveillance fda 2-11-14
Introduction to post marketing drug safety surveillance fda 2-11-14
 
Periodic Safety Update Report (PSUR)
Periodic Safety Update Report (PSUR)Periodic Safety Update Report (PSUR)
Periodic Safety Update Report (PSUR)
 
Evaluating and Investigating Drug Safety Signals with Public Databases
Evaluating and Investigating Drug Safety Signals with Public DatabasesEvaluating and Investigating Drug Safety Signals with Public Databases
Evaluating and Investigating Drug Safety Signals with Public Databases
 
Pharmacovigilance signal and signal detection
Pharmacovigilance signal and signal detectionPharmacovigilance signal and signal detection
Pharmacovigilance signal and signal detection
 
Presentation: Periodic safety update reports
Presentation: Periodic safety update reportsPresentation: Periodic safety update reports
Presentation: Periodic safety update reports
 
Monitoring of medical literature(MLM)
Monitoring of medical literature(MLM)Monitoring of medical literature(MLM)
Monitoring of medical literature(MLM)
 
Importance of aggregate reporting in pharmacovigilance
Importance of aggregate reporting in pharmacovigilanceImportance of aggregate reporting in pharmacovigilance
Importance of aggregate reporting in pharmacovigilance
 
Periodic Safety Update Reports: Some commonly asked questions
Periodic Safety Update Reports: Some commonly asked questionsPeriodic Safety Update Reports: Some commonly asked questions
Periodic Safety Update Reports: Some commonly asked questions
 
Literature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv   what are we doing at galderma elsevier webinarLiterature monitoring for pv   what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinar
 
TGA Presentation: Pharmacovigilance inspections
TGA Presentation: Pharmacovigilance inspectionsTGA Presentation: Pharmacovigilance inspections
TGA Presentation: Pharmacovigilance inspections
 
E2B(R2) vs E2B(R3) ICSR ELEMENTS
E2B(R2) vs E2B(R3) ICSR ELEMENTSE2B(R2) vs E2B(R3) ICSR ELEMENTS
E2B(R2) vs E2B(R3) ICSR ELEMENTS
 
PSUR
PSURPSUR
PSUR
 
Adverse Drug Reactions - Katalyst HLS
Adverse Drug Reactions - Katalyst HLSAdverse Drug Reactions - Katalyst HLS
Adverse Drug Reactions - Katalyst HLS
 
Practical Signal Management
Practical Signal ManagementPractical Signal Management
Practical Signal Management
 

Viewers also liked

Freyr Pharmacolvigilance Brochure
Freyr Pharmacolvigilance BrochureFreyr Pharmacolvigilance Brochure
Freyr Pharmacolvigilance BrochureFaiz Shariff
 
Adverse Event Analysis
Adverse Event AnalysisAdverse Event Analysis
Adverse Event AnalysisSenthil Kumar
 
Signal Detection With Oracle Products by Dipti Kadam, DBMS Consulting
Signal Detection With Oracle Products by Dipti Kadam, DBMS ConsultingSignal Detection With Oracle Products by Dipti Kadam, DBMS Consulting
Signal Detection With Oracle Products by Dipti Kadam, DBMS ConsultingUntil ROI
 
Quantitative methods of signal detection
Quantitative methods of signal detectionQuantitative methods of signal detection
Quantitative methods of signal detectionFrancois MAIGNEN
 
Bayesian estimations of strong toxic signals [compatibility mode]
Bayesian estimations of strong toxic signals [compatibility mode]Bayesian estimations of strong toxic signals [compatibility mode]
Bayesian estimations of strong toxic signals [compatibility mode]Bhaswat Chakraborty
 
Reporting Methods _ Global Pharmacovigilance1
Reporting Methods _ Global Pharmacovigilance1Reporting Methods _ Global Pharmacovigilance1
Reporting Methods _ Global Pharmacovigilance1Hafsa Hafeez
 
Data Mining & Signal Detection In Pv
Data Mining & Signal Detection In PvData Mining & Signal Detection In Pv
Data Mining & Signal Detection In PvUntil ROI
 
Common arab guidelines in pharmacovigilance
Common arab guidelines in pharmacovigilanceCommon arab guidelines in pharmacovigilance
Common arab guidelines in pharmacovigilanceNahla Amin
 
Pharmacovigilance organisation
Pharmacovigilance organisationPharmacovigilance organisation
Pharmacovigilance organisationSomya Solanki
 
ARGUS Query Process Overview_Katalyst HLS
ARGUS Query Process Overview_Katalyst HLSARGUS Query Process Overview_Katalyst HLS
ARGUS Query Process Overview_Katalyst HLSKatalyst HLS
 
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCEAN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCERamakrishna K
 
Pharmacovigilance in USA and Europe_Katalyst HLS
Pharmacovigilance in USA and Europe_Katalyst HLSPharmacovigilance in USA and Europe_Katalyst HLS
Pharmacovigilance in USA and Europe_Katalyst HLSKatalyst HLS
 
Introduction to Pharmacovigilance Signal Detection
Introduction to Pharmacovigilance Signal DetectionIntroduction to Pharmacovigilance Signal Detection
Introduction to Pharmacovigilance Signal DetectionPerficient
 
All about Clinical Trials_Katalyst HLS
All about Clinical Trials_Katalyst HLSAll about Clinical Trials_Katalyst HLS
All about Clinical Trials_Katalyst HLSKatalyst HLS
 
Pharmacovigilance Process Work Flow - Katalyst HLS
Pharmacovigilance Process Work Flow - Katalyst HLSPharmacovigilance Process Work Flow - Katalyst HLS
Pharmacovigilance Process Work Flow - Katalyst HLSKatalyst HLS
 
Blood pressure regulation 2013
Blood pressure regulation 2013Blood pressure regulation 2013
Blood pressure regulation 2013Nyunt Wai
 
Special Tests - Knee
Special Tests - KneeSpecial Tests - Knee
Special Tests - KneeJulie Jane
 

Viewers also liked (20)

Freyr Pharmacolvigilance Brochure
Freyr Pharmacolvigilance BrochureFreyr Pharmacolvigilance Brochure
Freyr Pharmacolvigilance Brochure
 
Adverse Event Analysis
Adverse Event AnalysisAdverse Event Analysis
Adverse Event Analysis
 
Signal Detection With Oracle Products by Dipti Kadam, DBMS Consulting
Signal Detection With Oracle Products by Dipti Kadam, DBMS ConsultingSignal Detection With Oracle Products by Dipti Kadam, DBMS Consulting
Signal Detection With Oracle Products by Dipti Kadam, DBMS Consulting
 
Quantitative methods of signal detection
Quantitative methods of signal detectionQuantitative methods of signal detection
Quantitative methods of signal detection
 
Bayesian estimations of strong toxic signals [compatibility mode]
Bayesian estimations of strong toxic signals [compatibility mode]Bayesian estimations of strong toxic signals [compatibility mode]
Bayesian estimations of strong toxic signals [compatibility mode]
 
Reporting Methods _ Global Pharmacovigilance1
Reporting Methods _ Global Pharmacovigilance1Reporting Methods _ Global Pharmacovigilance1
Reporting Methods _ Global Pharmacovigilance1
 
HySynth Pharmacovigilance
HySynth PharmacovigilanceHySynth Pharmacovigilance
HySynth Pharmacovigilance
 
Data Mining & Signal Detection In Pv
Data Mining & Signal Detection In PvData Mining & Signal Detection In Pv
Data Mining & Signal Detection In Pv
 
Common arab guidelines in pharmacovigilance
Common arab guidelines in pharmacovigilanceCommon arab guidelines in pharmacovigilance
Common arab guidelines in pharmacovigilance
 
Pharmacovigilance organisation
Pharmacovigilance organisationPharmacovigilance organisation
Pharmacovigilance organisation
 
ARGUS Query Process Overview_Katalyst HLS
ARGUS Query Process Overview_Katalyst HLSARGUS Query Process Overview_Katalyst HLS
ARGUS Query Process Overview_Katalyst HLS
 
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCEAN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
 
Pharmacovigilance in USA and Europe_Katalyst HLS
Pharmacovigilance in USA and Europe_Katalyst HLSPharmacovigilance in USA and Europe_Katalyst HLS
Pharmacovigilance in USA and Europe_Katalyst HLS
 
Introduction to Pharmacovigilance Signal Detection
Introduction to Pharmacovigilance Signal DetectionIntroduction to Pharmacovigilance Signal Detection
Introduction to Pharmacovigilance Signal Detection
 
All about Clinical Trials_Katalyst HLS
All about Clinical Trials_Katalyst HLSAll about Clinical Trials_Katalyst HLS
All about Clinical Trials_Katalyst HLS
 
Pharmacovigilance Process Work Flow - Katalyst HLS
Pharmacovigilance Process Work Flow - Katalyst HLSPharmacovigilance Process Work Flow - Katalyst HLS
Pharmacovigilance Process Work Flow - Katalyst HLS
 
Basics in ct
Basics in ctBasics in ct
Basics in ct
 
Blood pressure regulation 2013
Blood pressure regulation 2013Blood pressure regulation 2013
Blood pressure regulation 2013
 
Special Tests - Knee
Special Tests - KneeSpecial Tests - Knee
Special Tests - Knee
 
BIOPSY
BIOPSYBIOPSY
BIOPSY
 

Similar to safety-aggregate-reporting-and-analytics-aag

pharmacovigilance set up poster
pharmacovigilance set up posterpharmacovigilance set up poster
pharmacovigilance set up posterPriti Gupta
 
Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6Holly Devine
 
Cliniminds- Skill Development Program in Pharmacovigilance
Cliniminds- Skill Development Program in PharmacovigilanceCliniminds- Skill Development Program in Pharmacovigilance
Cliniminds- Skill Development Program in PharmacovigilanceCliniminds India
 
Updated capabilities overview1
Updated  capabilities overview1Updated  capabilities overview1
Updated capabilities overview1malbergo
 
Literature screening for pharmacovigilance 190818
Literature screening for pharmacovigilance 190818Literature screening for pharmacovigilance 190818
Literature screening for pharmacovigilance 190818Marnix Wieffer
 
Clinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
Clinical evaluation report cer in a more stringent regulatory- Pepgra HealthcareClinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
Clinical evaluation report cer in a more stringent regulatory- Pepgra HealthcarePEPGRA Healthcare
 
Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...
Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...
Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...Perficient, Inc.
 
The secret formula to getting health tech to market
The secret formula to getting health tech to marketThe secret formula to getting health tech to market
The secret formula to getting health tech to marketDr Hugh Harvey
 
Pharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with ProjectPharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with ProjectBioMed Informatics
 
Delivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and valueDelivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and valueKishan Patel, MBA
 
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...Bhaswat Chakraborty
 
MEG + Clinical Pharmacy Use Cases - An Overview
MEG + Clinical Pharmacy Use Cases - An OverviewMEG + Clinical Pharmacy Use Cases - An Overview
MEG + Clinical Pharmacy Use Cases - An OverviewEdel Churchill
 
The Fundamentals of HIPAA Privacy & Security Risk Management
The Fundamentals of HIPAA Privacy & Security Risk ManagementThe Fundamentals of HIPAA Privacy & Security Risk Management
The Fundamentals of HIPAA Privacy & Security Risk ManagementKeySys Health
 
Computer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
Computer Software Assurance (CSA): Understanding the FDA’s New Draft GuidanceComputer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
Computer Software Assurance (CSA): Understanding the FDA’s New Draft GuidanceGreenlight Guru
 

Similar to safety-aggregate-reporting-and-analytics-aag (20)

pharmacovigilance set up poster
pharmacovigilance set up posterpharmacovigilance set up poster
pharmacovigilance set up poster
 
Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6
 
Cliniminds- Skill Development Program in Pharmacovigilance
Cliniminds- Skill Development Program in PharmacovigilanceCliniminds- Skill Development Program in Pharmacovigilance
Cliniminds- Skill Development Program in Pharmacovigilance
 
Updated capabilities overview1
Updated  capabilities overview1Updated  capabilities overview1
Updated capabilities overview1
 
Literature screening for pharmacovigilance 190818
Literature screening for pharmacovigilance 190818Literature screening for pharmacovigilance 190818
Literature screening for pharmacovigilance 190818
 
Clinical Trials
Clinical TrialsClinical Trials
Clinical Trials
 
Clinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
Clinical evaluation report cer in a more stringent regulatory- Pepgra HealthcareClinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
Clinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
 
Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...
Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...
Identifying Safety Signals by Data Mining the FDA Adverse Event Reporting Sys...
 
Kpo solutions
Kpo solutionsKpo solutions
Kpo solutions
 
The secret formula to getting health tech to market
The secret formula to getting health tech to marketThe secret formula to getting health tech to market
The secret formula to getting health tech to market
 
Pharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with ProjectPharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with Project
 
Delivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and valueDelivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and value
 
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
 
MEG + Clinical Pharmacy Use Cases - An Overview
MEG + Clinical Pharmacy Use Cases - An OverviewMEG + Clinical Pharmacy Use Cases - An Overview
MEG + Clinical Pharmacy Use Cases - An Overview
 
Health quality management
Health quality managementHealth quality management
Health quality management
 
Clinical Trials
Clinical TrialsClinical Trials
Clinical Trials
 
Clinical Trials
Clinical TrialsClinical Trials
Clinical Trials
 
The Fundamentals of HIPAA Privacy & Security Risk Management
The Fundamentals of HIPAA Privacy & Security Risk ManagementThe Fundamentals of HIPAA Privacy & Security Risk Management
The Fundamentals of HIPAA Privacy & Security Risk Management
 
Computer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
Computer Software Assurance (CSA): Understanding the FDA’s New Draft GuidanceComputer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
Computer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
 
PV Audit
PV AuditPV Audit
PV Audit
 

safety-aggregate-reporting-and-analytics-aag

  • 1. New Requirements for Benefit-Risk Assessments Evolving global pharmacoviglance regulations have recently put the spot-light on finding better and quicker ways to measure and assess medicinal product benefit-risk profiles through new requirements and guidelines. Quintiles can help you better understand and comply with these changing regulations through our safety aggregate reporting and benefit-risk assessment capabilities. Through our experienced staff, best-in-class processes, and proprietary technology, we are able to deliver medical, scientific and regulatory reports that are timely, insightful, and stand up to regulatory scrutiny. Outstanding Pharmacovigilance Delivery  Zero critical findings from customer audits1  99% compliance for on-time reporting to health authorities1  200+ medical and clinical professionals including medical doctors, pharmacists, and life sciences graduates2 Bringing Together the Right Experts, Around the Globe  Cross-functional – Our team is comprised of physicians, pharmacists, pharmacoepidemiologists, and regulatory affairs professionals (including ex-FDA and European regulatory agency staff) with a wealth of medical, pharmaceutical, scientific and clinical expertise.  Highly Trained - All staff are trained and experienced in drug safety with particular focus on safety and efficacy analysis and regulatory requirements, to help deliver the highest quality and performance through our globally compliant suite of SOPs and templates underpinned by a range quality checklists.  Global – Our staff is housed across 8 global hubs located across North America, Europe and Asia. This globalization of services allows for extensive regionalized expertise, local-language translation, flexibility, improved cost effectiveness and provides the ability to meet our client’s local requirements, while never losing sight of safety and risk management compliance on a global scale. 1 Source: Quintiles internal data. Metrics valid from November 2012 through November 2013. 2 Source: Quintiles internal HRPSC data valid as of July 2013. Safety Aggregate Reporting and Analytics Team Core Training Modules Aggregate Reporting Training  Knowledge of Systems and Processes  Training Transcript Review  Subject Matter Expert Mentoring Specialized Argus 7.0 Reports Training  Individualized One-on-One Reports Training  Subject Matter Expert Mentoring Project Specific Training • Product Safety Information (IB, CCDS, CCSI, USPI, SmPC) Electronic Learning Management • Safety Aggregate Reporting & Analytics Specific Electronic Standard Operating Procedure (eSOP) Documents and Assignments • Electronic Training (eTraining) Management System • Required Readings (Regulations/Guidances) • Report Specific Courses With Knowledge Tests • Process Maps • Safety Aggregate Reporting Manual of Style All team members receive extensive training and mentorship as part of onboarding and continuing education. Safety Aggregate Reporting & Analytics PHARMACOVIGILANCE INSIGHTS AT-A-GLANCE
  • 2. Contact Us: US Toll Free: 1 866 267 4479 Direct: +1 973 850 7571 On the web: www.quintiles.com/safety Email: clinical@quintiles.com Copyright © 2013 Quintiles. 02.02.20-122013 Proprietary Technology Driving Productivity, Compliance and Quality Our Safety Aggregate Reporting and Analytics database tracks productivity, quality and compliance all in one place. Productivity and Compliance are tracked by automation of key report milestones and tracked against actual delivery throughout the report lifecycle. The Quality component is measured by a range of detailed report-specific checklists that have been developed using Six-Sigma concepts. Our database generates reports and scorecards both during in-line and end-of line review to help enable both Quintiles and our customers to deliver top quality, on-time aggregate reports to regulators. The result? Increased transparency between Quintiles and our customers throughout the entire report production process, allowing us to continually improve and excel in our delivery. Safety Aggregate Reporting and Analytics Services Service Description Benefit Signal Detection and Analytics  Analysis of Similar Events  Suspected Unexpected Serious Adverse Reactions (SUSAR) and Events of Special Inerest (EOSI) listings  Routine signal detection and management (listings and count tables)  J-review or Spotfire analysis of blinded clinical trial data  Post-marketing Signal Detection: Oracle Empirica, FDA-AERS, WHOVigibase, Electronic Health Record (EHR) data  Post-marketing Signal Evaluation and Confirmation  Pharmacoepidemiological studies  Proprietary signal management tool enables tracking of validation, prioritization, assessment, actioning, and reporting of signals  Gain deeper insights into your proudct’s safety profile  Understand off-label use Aggregate Reporting  Developmental Safety Update Report (DSUR)  Periodic Benefit-Risk Evaluation Reports (PBRER)  Periodic Safety Update Reports (PSUR)  Periodic Adverse Drug Experience Report (PADER)  IND Annual Safety Reports  Pharmacovigilance Risk Assessment Committee (PRAC) responses / Regulatory Authority responses  Meet new aggregate reporting requirements across multiple countries and projects with one, dedicated team Benefit-Risk Management  Risk Management Program Development & Implementation  US: Risk Evaluation & Mitigation Strategy (REMS)  EU Risk Management Plan (RMP)  Safety Crisis Management  Data Analysis & Risk Communications  EU QPPV (Qualified Person for Pharmacovigilance for the EU)  Label Creation and Maintenance  Literature Search and ad hoc Benefit-Risk Assessments  Understand and communicate the evolving benefit-risk profile of your productrs sooner